Analysis of institutional factors influencing drug price in the context of the enhancement of drug quality / 中国药学杂志

ABSTRACT

OBJECTIVE: To explore the institutional pricing factors influencing the improvement of drug quality and stimulate the reasonable alignment of the drug quality and price. METHODS: clarify the interrelationship between the connotations of drug quality, drug quality and drug price with the assistance of the questionnaire formulated according to the findings of structured interviews with the experts based on the descriptive statistical analysis and structural equation modeling analysis of the 25 institutional factors influencing drug prices. RESULTS: The fact that drug price exerts impact on the improvement of drug quality is not a mere function of the drug pricing rules. Factors such as the business bribes in drug dealership, the large number of drug distribution links, the high fees and the ranking of pharmaceutical benefits scheme as well as the internal cost management of the enterprise are some of the key factors that affect the pricing policies. CONCLUSION: The price regulations and policies should be adjusted with clarifying the internal cost management policies as the focus. The pricing policies should be made to encourage the retraining initiatives, energy reservation and emissions reduction as well as the consistency between the drug quality and prices so as to resolve the issue of lacking the driving force to enhance the drug qualities in the manufacturing process.